FOSL2 Positively Regulates TGF-β1 Signalling in Non-Small Cell Lung Cancer

被引:35
作者
Wang, Junfeng [1 ]
Sun, Dawei [1 ]
Wang, Yanbo [1 ]
Ren, Fenghai [1 ]
Pang, Sainan [1 ]
Wang, Dandan [1 ]
Xu, Shidong [1 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Thorac Surg, Harbin, Peoples R China
基金
中国国家自然科学基金;
关键词
GROWTH-FACTOR-BETA; TGF-BETA; GENE-EXPRESSION; BREAST-CANCER; FRA-2; SMAD3; COACTIVATORS; FIBROBLASTS; METASTASIS; P300/CBP;
D O I
10.1371/journal.pone.0112150
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fos-related antigen 2 (FRA-2/FOSL2) belongs to the AP-1 transcription factor family. Although FOSL2 has been shown to be involved in diverse physiological and pathological processes, very little is known about the signalling pathways that regulate FOSL2 expression and the mechanisms of FOSL2 function. Here, we show that FOSL2 expression is regulated by TGF-beta 1 and that FOSL2 is required for TGF-beta 1-induced migration. We demonstrate that FOSL2 interacts with Smad3 in vitro and in vivo and thus up-regulates TGF-beta 1-induced signalling responses. Mechanistically, FOSL2 promotes P300 binding to Smad3 and the acetylation of Smad3 by P300. Furthermore, we show that the expression of FOSL2 correlates with activated Smad3 expression in clinical non-small cell lung cancer (NSCLC) samples. In summary, the present study indicates that FOSL2 facilitates TGF-beta 1-induced migration by interaction with Smad3 in NSCLC and suggests FOSL2 as a potential therapeutic target for NSCLC.
引用
收藏
页数:7
相关论文
共 23 条
[1]   TGF-β signaling in fibrosis [J].
Biernacka, Anna ;
Dobaczewski, Marcin ;
Frangogiannis, Nikolaos G. .
GROWTH FACTORS, 2011, 29 (05) :196-202
[2]   Regulation of microRNAs in cancer metastasis [J].
Bouyssou, Juliette M. C. ;
Manier, Salomon ;
Daisy Huynh ;
Issa, Samar ;
Roccaro, Aldo M. ;
Ghobrial, Irene M. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1845 (02) :255-265
[3]   Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism [J].
Bozec, Aline ;
Bakiri, Latifa ;
Jimenez, Maria ;
Rosen, Evan D. ;
Catala-Lehnen, Philip ;
Schinke, Thorsten ;
Schett, Georg ;
Amling, Michael ;
Wagner, Erwin F. .
JOURNAL OF CELL SCIENCE, 2013, 126 (23) :5432-5440
[4]   Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production [J].
Bozec, Aline ;
Bakiri, Latifa ;
Jimenez, Maria ;
Schinke, Thorsten ;
Amling, Michael ;
Wagner, Erwin F. .
JOURNAL OF CELL BIOLOGY, 2010, 190 (06) :1093-1106
[5]   LOXL4 Is Induced by Transforming Growth Factor β1 through Smad and JunB/Fra2 and Contributes to Vascular Matrix Remodeling [J].
Busnadiego, Oscar ;
Gonzalez-Santamara, Jose ;
Lagares, David ;
Guinea-Viniegra, Juan ;
Pichol-Thievend, Cathy ;
Muller, Laurent ;
Rodriguez-Pascual, Fernando .
MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (12) :2388-2401
[6]   Fos-related antigen 2 (Fra-2) memorizes photoperiod in the rat pineal gland [J].
Engel, L ;
Gupta, BBP ;
Lorenzkowski, V ;
Heinrich, B ;
Schwerdtle, I ;
Gerhold, S ;
Holthues, H ;
Vollrath, L ;
Spessert, R .
NEUROSCIENCE, 2005, 132 (02) :511-518
[7]   The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation [J].
Feng, XH ;
Zhang, Y ;
Wu, RY ;
Derynck, R .
GENES & DEVELOPMENT, 1998, 12 (14) :2153-2163
[8]   Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators [J].
Ghosh, AK ;
Yuan, W ;
Mori, Y ;
Varga, J .
ONCOGENE, 2000, 19 (31) :3546-3555
[9]   Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition [J].
Heldin, Carl-Henrik ;
Landström, Marene ;
Moustakas, Aristidis .
CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) :166-176
[10]   Smad3 is acetylated by p300/CBP to regulate its transactivation activity [J].
Inoue, Y. ;
Itoh, Y. ;
Abe, K. ;
Okamoto, T. ;
Daitoku, H. ;
Fukamizu, A. ;
Onozaki, K. ;
Hayashi, H. .
ONCOGENE, 2007, 26 (04) :500-508